Page last updated: 2024-09-05

l 365031 and clonazepam

l 365031 has been researched along with clonazepam in 1 studies

*Clonazepam: An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses. [MeSH]

*Clonazepam: An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses. [MeSH]

Compound Research Comparison

Studies
(l 365031)
Trials
(l 365031)
Recent Studies (post-2010)
(l 365031)
Studies
(clonazepam)
Trials
(clonazepam)
Recent Studies (post-2010) (clonazepam)
7002,719239519

Protein Interaction Comparison

ProteinTaxonomyl 365031 (IC50)clonazepam (IC50)
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)0.0017
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)0.0017
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)0.0017
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)0.0017
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)0.0017
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)0.0017
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)0.0017
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)0.0017
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)0.0017
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)0.0017
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)0.0017
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)0.0017
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)0.0017
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)0.0017
GABA theta subunitRattus norvegicus (Norway rat)0.0017
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)0.0017

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson, PS; Bock, MG; Chang, RS; DiPardo, RM; Evans, BE; Freidinger, RM; Lundell, GF; Rittle, KE; Veber, DF; Whitter, WL1

Other Studies

1 other study(ies) available for l 365031 and clonazepam

ArticleYear
Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists.
    Journal of medicinal chemistry, 1988, Volume: 31, Issue:12

    Topics: Administration, Oral; Animals; Benzodiazepines; Chemical Phenomena; Chemistry; Cholecystokinin; Drug Design; Mice; Receptors, Cholecystokinin; Receptors, GABA-A; Structure-Activity Relationship

1988